A Multicentre, Randomised, Open-Label, Prospective Study to Estimate the Add-On Effects Of Memantine as Ebixa<sup>®</sup> Oral Pump (Solution) on Language in Patients with Moderate to Severe Alzheimer's Disease Already Receiving Donepezil (ROMEO-AD).

Neurol Ther · 2023 · PMC10310610 · PMID 37245175

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

However, the combination of donepezil and memantine group showed a decreasing trend in ROSA scores.

also in 47,180 other papers

showed a trendno p-value reported

Regarding the WAB test reflecting language function, both groups showed a trend toward improvement in language at 24 weeks compared to baseline.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.